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ase DNMT1 cells (Lee et al., 2001b). These regions also
were observed to be associated with acetylated histone
(Avni et al., 2002; Fields et al., 2002; Guo et al., 2002).Summary
Expression of a reporter-containing transgene was en-
hanced if all the above regions were included, sug-IL-4 secreting and nonsecreting cells from Th2 cul-
tures have a similar probability of producing IL-4 upon gesting the importance of these sites in the regulation
of IL-4 expression (Lee et al., 2001a). Recently, the Il4/subsequent stimulation, implying that there is sto-
chastic element in IL-4 production by stimulated Th2 Il5/Il13 genes have been shown to be regulated by a
locus control region located in the linked RAD50 genecells. Purified IL-4 producers and nonproducers have
similar Gata3 and c-maf mRNA expression. Il4 gene (Lee et al., 2003).
Initially, the relatively low proportion of T cells thataccessibility, analyzed by restriction enzyme accessi-
bility (REA) at sites in the promoter, in the second produce IL-4 in recently differentiated Th2 cell popula-
tions was explained by a correspondingly low proportionintron (DNase I hypersensitivity sites HSII and HSIII)
and in CNS-1 in the two populations was also similar. of cells in which one or both of the Il4 alleles had ac-
quired an “open” conformation and became capable ofHowever, upon TCR stimulation, site VA, which is 5 kB
3of exon 4, displayed a striking increase in accessibil- high-rate Il4 transcription (Bird et al., 1998; Gett and
Hodgkin, 1998). However, we showed that cells fromity but REA was 2- to 3-fold greater in producers than
nonproducers. Cyclosporin A treatment inhibited VA “early” Th2 cultures that were separated based on pro-
duction or lack of production of IL-4 had similar levelsopening, implying the involvement of NFAT in in-
creased VA accessibility. Induction of VA accessibility of Gata3 mRNA, suggesting that both the producers and
nonproducers might be differentiated Th2 cells (Hu-Liis sensitive to cycloheximide, suggesting an additional
factor(s) is needed. Thus, opening of VA is a probabilis- et al., 2001). Furthermore, when these cells were
“rested” and restimulated in the absence of IL-4, bothtic event determining which Th2 cells transcribe Il4.
the “producers” and “nonproducers” gave rise, on sub-
sequent stimulation, to IL-4-producing cells (Hu-Li etIntroduction
al., 2001). In most cases, the proportion of IL-4-produc-
ing cells from the two populations was similar or onlyInterleukin-4 (IL-4) is a cytokine that regulates immuno-
globulin class switching to IgE and development of Th2 slightly enriched among the former IL-4-producers (Hu-
Li et al., 2001). This led us to postulate that culture underCD4 T cells. As such, it plays a crucial role in allergic
inflammatory responses (reviewed in Glimcher and Mur- Th2-inducing conditions caused uniform differentiation
of naive CD4 T cells into Th2 cells and that a stochasticphy, 2000; Nelms et al., 1999; O’Garra and Arai, 2000;
Seder and Paul, 1994). Recent studies have demon- process determined whether a cell would actually tran-
scribe Il4. Indeed, we argued that such probabilisticstrated that the process through which naive CD4 T cells
develop into Th2 cells is associated with “opening” of control of Il4 transcription could explain the monoallelic
expression often seen for Il4 and might have significancethe Il4 gene (reviewed in Ansel et al., 2003; Grogan and
Locksley., 2002; Murphy and Reiner., 2002; Smale and in the control of IL-4 function, being well adapted to
controlling quantal responses by antigen-presentingFisher., 2002). Thus, in Th2 cells, there are distinct sites
of DNase I hypersensitivity in the Il4 gene that are not cells, such as B cells, interacting with Th2 cells. This
would imply that both IL-4-producing and IL-4-nonpro-found in Th1 cells. These include regions in conserved
noncoding sequence (CNS)-1 (Loots et al., 2000; Mohrs ducing Th2 cells have similar patterns of chromatin ac-
cessibility. In this paper, we sought to determine theet al., 2001; Takemoto et al., 1998, 2000), located be-
tween the Il13 and Il4 genes, in the Il4 promoter (HSI), pattern of accessibility at the Il4 locus in IL-4-producing
and nonproducing cells purified from Th2-inducing cul-in the second intron of the Il4 gene (HSII and HSIII), and
3 of exon 4 (HSV) (Agarwal and Rao, 1998; Henkel et tures. Our results show that these cells have a generally
similar pattern of accessibility and strongly suggest thatal., 1992). In the vicinity of HSV is site VA that becomes
transiently hypersensitive to DNase I when Th2 cells are site VA may be the target of probabilistic control.
stimulated through the T cell receptor (Agarwal and Rao,
2000). The Il4 gene also shows extensive demethylation Results
of CpGs during Th2 differentiation. Areas of demethyl-
ation during Th2 differentiation have been found in the Restriction Endonuclease Accessibility
CNS1, intron 1, intron 2, and 3 of exon 4 (Bird et al., at the Il4 Locus
1998; Guo et al., 2002; Lee et al., 2002; L. Tykocinski, To quantitatively analyze the degree of accessibility of
the Il4 gene, a REA assay with real-time PCR quantita-
tion was used. The restriction enzyme RsaI was used*Correspondence: wepaul@nih.gov
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Figure 1. Map of Murine Il4 and Murine Ifn
(A) Map of the murine Il4/Il13 locus showing
the five regions used to study the chromatin
accessibility. CNS-1 is the highly conserved
Il4/Il13 intergenic region. HSII and HSIII indi-
cate the second and the third Il4 DNase I
hypersensitive sites, located in intron 2. HSVA
indicates the inducible DNase I hypersensi-
tive site 5 kb downstream of the fourth exon
of Il4.
(B) Map of the murine Ifn locus showing the
two regions used to study chromatin accessi-
bility. HSI and HSIII indicate the first and the
third DNase I hypersensitive sites.
to measure the accessibility of HSII, HSIII, CNS, and VA going Th2 priming was also observed (Figure 2B). Cells
being primed under Th2 and Th1 cells had similar REAsof Il4 gene. The restriction enzyme HaeIII was used to
measure the accessibility of Il4 promoter. The degree at this site after 1 day culture; the Th2-primed cells
showed a 5-fold greater REA after 2 days of culture andto which the restriction enzyme cuts the cognate site
was taken as a measure of the accessibility of this region a 12-fold greater REA at the end of the first round of
priming. After three rounds of priming under Th2 condi-of chromatin and was measured with a two-step nested
PCR strategy. After nuclear preparations had been ex- tions, REA at HSIII was 52-fold greater than in compara-
bly primed Th1 cells.posed to RsaI or HaeIII, DNA was purified and an adap-
tor, consisting of paired long and short strands, was Neither HSII nor HSIII REA was found to be substan-
tially different between unstimulated cells and cells ana-ligated to the cut end. A gene-specific primer and a
primer complementary to the distal portion of the long lyzed after 3.5 hr of stimulation with immobilized anti-
CD3 and anti-CD28. By contrast, it has been shownstrand of the linker were used for priming amplification.
At the second step, the gene-specific primer used above that accessibility at the Il4 VA site is dependent on TCR
stimulation (Figure 2C) (Agarwal and Rao, 1998). Cellsand a nested primer complementary to a sequence in
the more proximal region of the long strand of the linker primed under Th2 conditions did not display a substan-
tially greater degree of REA than cells primed under Th1were used in a real-time PCR assay, with a fluorescent
gene-specific probe. Similar analysis of the actin pro- conditions after 1 day, 2 days, or even at the conclusion
of the first round of priming. Stimulating “one-roundmoter was used as a control. The results are expressed
as a ratio of cutting at Il4 to cutting at actin. Utilizing primed” Th2 cells with anti-CD3 and anti-CD28 led to a
54-fold greater REA than comparably stimulated Th1this method, two sites in the Ifn locus (Ifn HSI and
HSIII) (Agarwal and Rao, 1998), one in CNS-1, four sites cells. However, after cells had been primed three times,
even prior to restimulation, the VA site was 33-fold morein the IL4 promoter (-106, -252, -422, and -837), two
sites in the second intron of Il4 (HSII, HSIII), and one accessible in Th2 than in Th1 cells. This difference rose
to 100-fold upon anti-CD3/anti-CD28 rechallenge.site 5 kB 3 of exon 4 (VA) were analyzed.
Naive cells were purified from line 94 mice and cul- At CNS-1 site, Th2 had only a modestly increased
REA at the end of the first round of priming (Figure 2D).tured with irradiated T cell-depleted spleen cells (APC)
and cytochrome C peptide (1 M) under Th1 conditions The difference was only 2.3-fold. Three round-primed
Th2 cells showed a 9-fold greater REA than comparably(IL-2, IL-12, and anti-IL-4) or Th2 conditions (IL-2, IL-4,
anti-IL-12, and anti-IFN) for different periods of time. At primed Th1 cells. There was no further increase upon
TCR stimulation. Whether the differences in Th2/Th1the HSII site in the Il4 locus (see Figure 1A), a difference
between Th1 and Th2-differentiated cells in REA occurs ratio of REA at different sites in the Il4 genetic region
reflect absolute differences in the degree of accessibilityvery quickly. Within 1 day of culture of CD4 T cells under
Th2 conditions, the REA was 6.2-fold greater than the at these sites is uncertain but they do indicate that each
of these sites is substantially more accessible in Th2same cells cultured under Th1 conditions (Figure 2A)
and 46-fold greater by 2 days of culture. By the end of than in Th1 cells.
the first round of priming (4 days for each round), the
ratio was 52. This difference was maintained when the Restriction Endonuclease Accessibility
at the Ifn Locuscells were rested in IL-2 containing medium (20 units/ml)
for 10 days. After three rounds of stimulation under Th2 At the Ifng HSI and HSIII sites (Figure 1B), greater acces-
sibility of Th1 cells is TCR stimulation dependent. Afterconditions, the ratio was 315. Three hour stimulation
with immobilized anti-CD3/anti-CD28 did not change 2 days culture, a 9.5-fold-greater REA was found in Th1-
than Th2-primed cells (Figure 2E). At the conclusion ofthe REA ratio at HSII between Th1 and Th2.
At the Il4 HSIII site, an increase in REA of cells under- the first round of priming, that difference was only 2.3-
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Figure 2. REA Shows Significant Differences
between Comparably Primed Th1 and Th2
Cells
CD4 T cells isolated from Line 94 mice were
primed with cytochrome C- and T-depleted,
irradiated APCs under either Th1 conditions
or Th2 conditions. “1D” and “2D” represent
1 day or 2 day cultures. “1*” represents cells
analyzed immediately after the first 4 day
round of priming. “1*sti” represents first-
round primed cells analyzed after a 3.5 hr
stimulation with immobilized anti-CD3 and
anti-CD28. “1*resting” represents first-round
primed cells analyzed after resting in IL-2
containing medium for 10 days. “3*” repre-
sents cells analyzed immediately after the
third round of priming. “3*sti” represents
three-round primed cells analyzed after 3.5
hr stimulation with immobilized anti-CD3 and
anti-CD28. For 1 day or 2 days cultures,
T cells were purified with anti-CD4 beads to
remove APC. In longer cultures, APCs were
no longer detectable and CD4 T cells were
directly used for analysis. (A)–(D) report the
REA ratio at indicated sites in the Il4 locus of
Th2 cells and Th1 cells primed in parallel. (E)
and (F) report the ratio at indicated sites in
Ifn locus of Th1 cells and Th2 cells primed
in parallel.
fold; stimulation of such cells with anti-CD3/anti-CD28 nonproducers was verified by the 128-fold difference in
Il4 mRNA between these populations. Neither Gata3 orresulted in an increase in the REA ratio to 7.9-fold, sug-
gesting the regulation of accessibility at this site relied c-maf mRNA differed between the cell populations. The
same results were obtained from Th2 cells primed foron TCR signaling. After three rounds of priming, there
was a 5-fold difference between Th1 and Th2 cells that three rounds (data not shown).
increased to 18-fold upon anti-CD3/anti-CD28 stimu-
lation. Th2-Primed IL-4-Producing and Nonproducing Cells
Express Similar Degrees of Accessibility toAt the Ifng HSIII site, a difference between Th1- and
Th2-primed cells was not observed until the stimulation Endonucleases at Il4 HSII, HSIII, CNS-1, and Promoter
As described in the Introduction, among CD4 T cellsof cells that had completed the first round of priming
(Figure 2F). Even after three rounds of priming, Th1- primed under Th2 conditions, those that produced IL-4
and those that did not had a similar potential to produceprimed cells had only a modest advantage (8.5-fold)
over Th2-primed cells, but after TCR stimulation, that IL-4 after rest and restimulation. To determine if their
degree of differentiation was similar at the level of Il4advantage rose to 56-fold.
gene accessibility, we separated these cell populations
and analyzed them by REA (Figure 4).Th2-Primed IL-4-Producing and Nonproducing Cells
Express Similar Amounts of gata3 and c-maf mRNA At site Il4 HSII, as we observed in the previous experi-
ment (Figure 2A), one-round primed Th2 cells have aCells that had been primed under Th2 conditions for
one round and that had been stimulated with immobi- much greater REA than comparably primed Th1 cells.
In Figure 4A, we show actual ratios of Il4/actin REAlized anti-CD3 and anti-CD28 for 3.5 hr were separated
into IL-4-secreting and nonsecreting cells using cyto- rather than the ratio of Th2 to Th1 cells. It can be seen
that naive cells have a slightly greater REA than do one-kine capture and cell sorting (Figure 3). To test the idea
that the cells that did or did not produce IL-4 had been round primed Th1 cells, although the significance of
this is uncertain since it presupposes that there are nosimilarly primed down the Th2 pathway, we analyzed the
expression of two of the most important transcription differences in actin accessibility in the two cell types.
Upon TCR stimulation for 3.5 hr, no change in accessibil-factors associated with Th2 differentiation, Gata3 and
c-maf, by real-time PCR (Ho et al., 1996; Lee et al., 2000; ity at HSII is noted. The separated IL-4-producing and
nonproducing cells showed REAs that were similar toKim et al., 1999; Ouyang et al., 1998; Zheng and Flavell.,
1997). The efficiency of separation of IL-4 producers and one another and to that of unseparated cells. Results
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At Il4 HSIII, accessibility in naive cells and in one-
round primed Th1 cells is low and is substantially higher
in one-round primed Th2 cells (Figure 4B). No changes
were observed after 3.5 hr of anti-CD3/ anti-CD28 stimu-
lation. The separated IL-4-producing and nonproducing
cells showed similar REAs. In an independent experi-
ment, IL-4-producing and nonproducing cells separated
from one-round Th2 cells also showed similar degrees
of accessibility at Il4 HSIII (Figure 4B).
At CNS1, the REA results were similar to those at HS
II and HS III, although less dramatic (Figure 4C). Indeed,
compared to naive cells, one-round Th2 cells increase
their REA relatively little, although accessibility is some-
what greater than in Th1 cells. There was no change in
REA after 3.5 hr of stimulation with immobilized anti-
CD3/anti-CD28 and the IL-4 and IL-4 cells were similar
in their REA.
At the Il4 promoter, accessibility at sites -106, -252,
-422, and -837, utilizing HaeIII to cleave nuclei, was
assessed (Figure 4D). In this case, we present the ratio
of REA of IL-4/IL-4 cells rather than absolute values;
this was done so all of the points could be shown on a
single graph. The ratios varied between 1.3 and 1.0,
indicating accessibility in the promoter was not signifi-
cantly different between producers and nonproducers.
Figure 3. Th2 Primed IL-4-Producing and Nonproducing Cells Ex-
REA of Il4 VA Reveals Differences in IL-4-Producerspress Similar Amounts of gata3 and c-maf
and NonproducersOne round-primed Th2 cells were stimulated with immobilized anti-
CD3 and anti-CD28 for 3.5 hr. IL-4-producing and nonproducing At Il4 site VA, one-round primed Th2 cells stimulated with
cells were separated by cytokine capture and cell sorting. RNAs anti-CD3/anti-CD28 showed much greater accessibility
were isolated from both cell populations and Il4, gata3, and c-maf than did unstimulated cells. Although both IL-4-produc-
mRNA amounts were analyzed by real-time RT-PCR. The results ing and IL-4-nonproducing Th2-primed cells display
reported have been adjusted to the internal control of 18s RNA.
striking increases in REA upon activation, the REAs are
greater for the IL-4 producers than nonproducers. This
was observed in 18 experiments. Two separate experi-from two independent experiments are shown Figure
4A. We also observed no difference in HSII REA in IL-4- ments using one-round primed Th2 cells are shown in
Figure 5Aand two experiments using three-roundproducers and nonproducers separated after three
rounds of Th2-priming (data not shown). primed Th2 cells are shown in Figure 5B. The REA ratio
Figure 4. Th2 Primed IL-4-Producing and
Nonproducing Cells Express a Similar Degree
of Accessibility to Endonuclease at the Il4
Promoter and at the HSII, HSIII, and CNS1
Sites
Naive CD4 T cells were purified from Line
94 mice. “1*Th1” indicates one round-primed
Th1cells. “1*Th2” and “1*Th2 sti” indicate one
round-primed Th2 cells without or with 3.5 hr
stimulation by immobilized anti-CD3 and anti-
CD28. After 3.5 hr stimulation, IL-4-producing
and nonproducing cells were separated by
cytokine capture and cell sorting methods.
“1*Th2 IL4” and “1*Th2 IL4-” indicate IL-4-
producing and nonproducing cells, respec-
tively. (A)–(C) shows the REA analysis at indi-
cated sites in the IL4 locus. (D) reports the
ratio of REA in nuclei from IL-4-producing and
IL-4-nonproducing cells at positions -106,
-252, -422, and -837.
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Figure 5. REA of VA Reveals Differences between IL-4-Producing and Nonproducing Cells
(A) REA at HSVA after one round of priming. The samples are those described in Figure 4. “U.D.” indicates undetectable.
(B) REA at HSVA after three rounds of priming. Three round-primed Th1 or Th2 cells were placed into IL-2-containing medium to rest for 2
days. They were analyzed immediately or after 3 hr stimulation with immobilized anti-CD3 and anti-CD28. At the end of stimulation, IL-4-
producing and nonproducing cells were purified. “3*Th1” and “3*Th1 sti” indicate the rested and stimulated three round-primed Th1 cells,
respectively. “3*Th2” and “3*Th2 sti” indicate the rested and stimulated three round-primed Th2 cells, respectively. “3*Th2 IL4” and “3*Th2
IL4-” indicate IL-4-producing and nonproducing cells separated from the three round-primed Th2 cells, respectively.
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of producers to nonproducers for the 18 experiments Upon stimulation with immobilized anti-CD3/anti-
CD28, the previously IL-4 cells increased their REA towas 2.7 / 0.32 (mean / std. error).
Because of the possibility that some of the IL-4 non- 46 while the previously IL-4 cells increased their REA
to 43. Both cell populations were separated into IL-4producers may simply have been stimulated less effi-
ciently than IL-4 producers and thus would show a less and IL-4 cells. The IL-4 cells derived from the popula-
tion that had initially been IL-4 had an REA of 113 whilerobust increase in REA than the IL-4 producers, we ex-
amined the degree of upregulation in CD69, CD25, and the IL-4 cells from this population had an REA of 16.
Among the cells that had been initially IL-4, the cellsthe downregulation of TCR V11 expression among the
IL-4-producers and IL-4-nonproducers (Figure 5C). No that produced IL-4 upon rechallenge had an REA of 106
while the IL-4 cells had an REA of 32. Thus, withoutdifferences in the relative expression of these “stimula-
tion-dependent” cell surface molecules was observed, reference to the previous IL-4 production history of the
cells, those cells that produce IL-4 have a similar REAimplying that the degree of stimulation in the IL-4-pro-
ducing and nonproducing cells was similar. at VA, which is 3- to 6-fold greater than cells that fail to
produce IL-4.Since the VA site has been reported to have four poten-
tial NFAT binding sites and NFAT has been shown to
bind to the VA site by chromatin immunoprecipitation, Stimulation-Induced Increase in VA Accessibilitywe asked whether there was a difference in nuclear Is Slow and Is Sensitive to Cycloheximide
localization of NFAT in Th2 cells that produce or do not and to Cyclosporin A
produce IL-4. Two round-primed Th2 cells were cultured The observation that stimulated IL-4-producers and
in IL-2 for 3 days and then stimulated with immobilized nonproducers, independent of their prior IL-4-producing
anti-CD3 and anti-CD28 on coverslips for 3.5 hr. The history, show reproducible differences in REA at site VAcells were fixed and stained with anti-NFATc2, anti-IL-4, suggests that the stochastic event involved in determin-
and DAPI. A total of 140 cells were examined and scored ing which Th2 cells will produce IL-4 and which will not
for the intensity of nuclear NFAT and the relative is associated with the degree of induced VA accessibility.amounts of cytosolic and nuclear NFAT both by visual To gain more information regarding this, we examined
analysis (without knowledge of whether the cells were the requirements for increased accessibility at VA moreIL-4 or IL-4) and through the use of the ImarisColoc carefully. No change in REA at VA was observed until 1 hranalysis program (Figure 5E). No differences between after stimulation with phorbol-12-myristate-13-acetate
the IL-4 and IL-4 cells were observed (Figure 5D), (phorbol ester, PMA) and ionomycin; a peak was
implying that the amount of nuclear NFAT is not the reached at 2 hr, which persisted for 24 hr (Figure 7A).
“random” event that determines the degree of induced The pace of increase in VA accessibility was similaraccessibility at VA and the likelihood that the cells would to that for the appearance of Il4 mRNA, as measured
produce IL-4. by real-time PCR analysis (Figure 7B). Interestingly, VA
remained accessible for 24 hr while Il4 mRNA levels
were quite low at 24 hr.Both IL-4 Producers and Nonproducers, when
Recultured and Restimulated, Give Rise to Producers The increase in REA was inhibited by EGTA (Figure
7A), implying that it was dependent upon Ca2. Further-and Nonproducers with Differences in VA REA
To test the possibility that there was a consistent rela- more, it was induced by ionomycin alone (Figure 7A),
indicating that increase in [Ca2]i was sufficient for in-tionship between increased REA at VA and IL-4 produc-
tion, we primed naive line 94 CD4 T cells with peptide creased accessibility at VA. Treatment with cyclosporin
A diminished the VA REA induction both by 2 hr PMA plusand APC. After 4 days under Th2 conditions, the cells
were stimulated and IL-4-producers and IL-4-nonpro- ionomycin stimulation (Figure 7A) and 3 hr immobilized
anti-CD3/anti-CD28 stimulation (Figure 7C), implyingducers separated by cytokine capture and cell sorting
(Figure 6). The separated IL-4 and the IL-4 cell popula- calcineurin action on NFAT plays an important role in the
increased accessibility of VA as a result of stimulation.tions were cultured for 48 hr with anti-IL-4, anti-IL-4R,
to prevent futher IL-4 signaling, and with IL-2. They were In addition, cycloheximide, a translational inhibitor,
prevented the increase in VA accessibility (Figure 7C),then restimulated for two rounds of 4 days each with
peptide and APC under ThN conditions, which includes suggesting that another factor(s) might be needed for
this induced accessibility. Both VA accessibility and IL-4anti-IL-4, anti-IL-4R, anti-IL-12, and anti-IFN. At the
end of the second round of restimulation, the cells were transcription appear to require a prior TCR-induced
translational event. These results suggest that inductionrested in anti-IL-4, anti-IL-4R, and IL-2 for 2 days. The
REA at VA was 10 for the cells that had been previously of Il4 mRNA and enhanced accessibility at VA are not
immediate-early responses to TCR engagement. Rather,IL-4. Those that had been IL-4 had an REA of 14.
(C) One round-primed Th2 cells were placed into IL-2-containing medium to rest for 2 days. Cells were either unstimulated or were stimulated
with immobilized anti-CD3 and anti-CD28 or with PMA and ionomycin for 3.5 or 4 hr. The cells were stained for cytosolic IL-4 and with anti-
CD69, anti-CD25, or anti-V11.
(D) Two round-primed Th2 cells were placed into IL-2-containing medium to rest for 3 days. Cells were stimulated, in the presence or absence
of CsA, with immobilized anti-CD3/CD28 (PB) on a coverslip for 4 hr and stained with anti-NFAT, anti-IL-4, and DAPI. Red indicates NFAT;
green indicates IL-4, and gray indicates DAPI.
(E) Summary of analysis (mean / S.D.) of the intensity of nuclear NFAT and the ratio of cytosolic and nuclear NFAT by visual analysis and
by the ImarisColoc program. P values were 0.44 and 0.19.
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Figure 6. IL-4 Producers and Nonproducers Give Rise to Producers and Nonproducers that Express High and Low VA REA
IL-4-producers and nonproducers were separated from one round-primed Th2 cells. They rested in anti-IL-4, anti-IL-4R, and IL-2 medium
for 2 days. They were stimulated through two additional rounds with 1 M cytochrome C and APC under ThN conditions, which includes anti-
IL-4, anti-IL-4R, anti-IL-12, and anti-IFN. At the end of the second round of stimulation, cells were put into anti-IL-4, anti-IL-4R, and IL-2
medium to rest for 2 days and then rechallenged for 3.5 hr with immobilized anti-CD3 and anti-CD28. IL-4-producing and nonproducing cells
from both populations were purified and REA at VA determined.
a factor(s) important in the opening of VA appears to be II of the Il4 gene. Similarly, these two cell types had
similar REAs at conserved noncoding site I, located ininduced in response to TCR/CD28 engagement or to
ionomycin. The strong correlation between induction of the Il13/Il4 intergenic region. This data is consistent with
the observation that both IL-4-producers and nonpro-VA accessibility and appearance of Il4 mRNA is consis-
tent with VA accessibility being a key factor in transcrip- ducers that have been primed under Th2 conditions
have the potential to produce IL-4 after rest and restimu-tion of the Il4 gene.
lation (Hu-Li et al., 2001).
Based on this, we have argued that there is a probabi-Discussion
listic element in the determination of Il4 transcription.
Furthermore, we observed that as priming proceedsAs outlined in the Introduction, two contending views
from one round to three rounds, the proportion of cellsof Th2 differentiation have been proposed. One holds
that produce IL-4 increases and there is a greater degreethat IL-4 production by a minority of cells primed under
of demethylation at CpGs in the Il4 gene and an increaseTh2 conditions is due to an inefficient process of induc-
in the amount of acetylated histone associated with vari-ing accessibility of the Il4 gene. Such accessibility oc-
ous Il4 sites (Guo et al., 2002). This is consistent withcurs only in those cells that actually produce IL-4 upon
the concept that the degree of accessibility of the Il4stimulation (Bird et al., 1998; Gett and Hodgkin, 1998).
gene determines its probability of expression.The alternative view is that all Th2 cells acquire in-
Indeed, Th2 T cell clones vary in the proportion ofcreased accessibility of their Il4 alleles and that some
cells that express Il4 or, in the case of mice in whichstochastic process determines which cells produce and
eGfp replaced the first exon of Il4, GFP upon T cellwhich do not produce IL-4 (Hu-Li et al., 2001).
stimulation (Guo et al., 2002). This proportion is a stableHere we have provided evidence that among a popula-
characteristic of the clones. Analysis of the state oftion of antigen-specific CD4 T cells stimulated with their
CpG methylation and of associated acetylated histonecognate peptide and antigen-presenting cells under
indicated that clones expressing a larger proportion ofTh2 conditions, the IL-4-producers and nonproducers
IL-4- or GFP-producing cells have a greater degree ofshowed a similar degree of restriction enzyme accessi-
accessibility than clones expressing a relatively low pro-bility at the Il4 promoter and at DNase I hypersensitivity
sites II and III, both located in the distal portion of intron portion of IL-4- or GFP-producing cells (Guo et al., 2002).
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Figure 7. Stimulation-Induced Increase in VA
Accessibility Is Slow and Is Sensitive to
Cycloheximide and to Cyclosporin A
Two round-primed Th2 cells were stimulated
for indicated periods with PMA (10 ng/ml) and
ionomycin (1 M) or with PMA or ionomycin
alone (A and B). CsA (50 ng/ml) or EGTA (0.8
mM) were added 30 min before PMA and
ionomycin stimulation. REA at VA (A) and Il4
mRNA, analyzed by real-time PCR (B), were
determined. Two round-primed Th2 cells
were stimulated with immobilized anti-CD3
and anti-CD28 for 3 hr (C and D). To some
samples, CsA (50 ng/ml) or cycloheximide (10
g/ml) were added 15 min prior to TCR stimu-
lation. VA REA (C) and Il4 mRNA (D) were ana-
lyzed.
A striking observation in the current work was that, individual cell is not either open or closed but that the
accessibility is dynamic depending upon an equilibriumin contrast to the similarity in degree of accessibility at
CNS1, the Il4 promoter, and at HSII and HSIII among of bound and unbound nuclear binding factors (Misteli,
2001). We would further argue that a given degree ofIL-4-producing and IL-4-nonproducing Th2 cells, a clear
difference was observed at site VA. accessibility is associated with a given probability of
transcription; in all cases that probability is substantiallyAccessibility at site VA is strikingly enhanced as a
result of TCR-mediated T cell activation and, in a large l. Thus, if one looks at all nonproducers, it would follow
that they would be overrepresented in cells that had lowseries of experiments, IL-4-producers have a 2- to 3-fold
greater REA than do IL-4 nonproducers. This is true REAs and thus low probabilities of transcription while
the producers would be overrepresented in cells thateven among cells that were separated based on their
capacity to produce IL-4 after initial Th2 priming. Both had high REAs and higher probabilities of expression,
but this would not be a simple all-or-none situation.the formerly IL-4 and IL-4 cells can, upon restimula-
tion, give rise to IL-4 producers and IL-4 nonproducers. TCR stimulation results in very rapid entry of NFAT
into the nucleus; however, VA accessibility is not ob-Again, the IL-4 producers have a greater REA at VA than
do the nonproducers. This difference cannot be ex- served until 1 hr after TCR stimulation and is not maximal
until 2 hr, a time course that is similar to that of appear-plained simply by less potent activation of the nonpro-
ducers since the degree of increase in CD69 and CD25 ance of Il4 mRNA in these cells. The amount of nuclear
NFAT among producers and nonproducers was theand decrease in V11 of the nonproducers and produc-
ers was similar. Interestingly, increase in REA at site VA same, indicating that the differential accessibility at VA
could not be explained by the total amount of NFAT incould be induced by ionomycin treatment alone and
was inhibited by cyclosporin A or by EGTA, indicating the nucleus. Additionally, cycloheximide can block the
increase in VA accessibility and appearance of Il4 mRNA,an important role for NFAT in the induction of accessibil-
ity. It has been shown that four NFAT binding sites exist indicating that a factor whose transcription is likely to
be stimulated by T cell activation is essential for VAin the vicinity of the VA DNase I hypersensitivity site and
that anti-NFAT can coprecipitate sequences from the opening and for Il4 transcription. Thus, NFAT binding
may be needed for the increased accessibility, whichVA region as well as from the Il4 promoter (Agarwal and
Rao, 1998). Thus, the binding of NFAT to VA as a result also depends upon an additional induced factor(s), or
the postulated induced factor opens site VA allowingof T cell activation and elevation of [Ca2]i may play a
role in the increase in VA accessibility. NFAT binding.
An alternative possibility is that Il4 transcription isSome concern may be raised as to whether a 2- to
3-fold difference in REA at site VA, despite its consis- responsible for the increased accessibility at VA. We
regard this as less likely for the following reasons. It hastency, may be sufficient to result in cells either producing
or not producing IL-4. We would argue that VA in an been shown that in mice in which VA has been deleted by
VA Determines Probabilistic IL-4 Production
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Purification of IL-4-Producing and Nonproducing Cellsgene targeting, IL-4 production is markedly diminished,
Th2 cells were stimulated with immobilized anti-CD3 (3 g/ml) andimplying that VA plays an important role in IL-4 produc-
anti-CD28 (3 g/ml) for 3.5 hr at 37C. Cells were harvested andtion and is not simply a “reporter” of IL-4 transcription
incubated with an anti-CD45-anti-IL4 bispecific antibody capture
(Solymar et al., 2002). Further, this role is probably not matrix (Miltenyi Biotec) for 5 min on ice. Cells were transferred to
to determine the accessibility of other sites in the Il4 warm cRPMI medium and placed in a 37C water bath. After 30 min
incubation with gentle mixing every 10 min, cells were washed withgene. Solymar et al. (2002) reported that DNase I hyper-
cold PBS. Matrix-captured IL-4 was detected with PE-anti-IL4. IL-4-sensitivity at sites HSII and HSIII was normally induced
producing and nonproducing cells were purified by FACSCaliber orin the VA knockout. Together, these observations are
on a MACS column.consistent with the concept that VA is an important deter- To do the VA “reset” experiment, one round-primed Th2 cells wereminant of transcription. Furthermore, the VA site is lo- separated into IL-4-producing and nonproducing cells. Both cell
cated more than 5 kB downstream of the polyA site in populations were placed into IL-2 (100 ng/ml), anti-IL-4 (20 g/ml),
and anti-IL-4R (20g/ml) to rest for 2 days. They were then culturedthe Il4 gene, suggesting it is not transcribed as part of
with APCs and cytochrome C for 2 more rounds under ThN condi-Il4 transcription so that it is unlikely that differences
tions, which include anti-IL-4 (20g/ml), anti-IL-4R (20g/ml), anti-in accessibility flow from elements of the transcription
IL-12 (10 g/ml), and anti-IFN (10 g/ml). Cells were rested for 2complex occupying VA. Finally, we do see a low level of days and then restimulated with immobilized anti-CD3 (3 g/ml) and
VA induction in the presence of CsA (Figures 7A and 7C) anti-CD28 (3 g/ml) for 3.5 hr and IL-4-producing and nonproducing
but IL-4 transcription is completely blocked, arguing cells were separated again.
that induced accessibility at VA is at least partially inde-
pendent of IL-4 transcription. Flow Cytometry
Harvested cells were fixed with 4% paraformadehyde, washed withThe concept that IL-4 production is determined by
0.1% BSA-containing PBS, and stored. For staining, cells were incu-probability of expression and that such probability is in
bated with PBS (for cell surface staining) or permeabilization bufferturn determined by the accessibility of Il4 alleles offers
(PBS supplemented with 0.1% BSA/0.1% Triton X-100) and variousan explanation for monoallelic expression of Il4 by CD4
antibodies for 20 min. The antibodies used were PE-anti-IL-4, FITC-
Th2 cells. Since the degree of accessibility of the Il4 anti-CD69, FITC-anti-CD25, and FITC-anti-V11. Cells were ana-
alleles in a given cell is associated with the likelihood lyzed on a FACSCalibur (Becton Dickinson, San Jose, CA).
that the cell will produce IL-4 and since that likelihood
is often quite low, it would be expected that the majority Restriction Endonuclease Accessibility
of cells that produce IL-4 do so only from one of the 1 	 106 cells were washed twice in cold PBS and resuspended in
lysis buffer (60 mM KCl, 15 mM NaCl, 5 mM MgCl2, 10 mM Tristwo alleles. This would be a purely stochastic mecha-
[pH 7.4], 300 mM sucrose, and 0.1% NP-40) with freshly suppliednism and would not imply any active process limiting
protease inhibitors. After cells were lysed on ice for 10 min, thebiallelic production of IL-4.
nuclei were pelleted at 2,000 rpm for 10 min at 4C. Nuclei wereWe have previously argued that regulating IL-4 pro-
then treated with 10 units of RsaI or HaeIII in digestion buffer (50
duction by determining the probability of IL-4 production mM NaCl, 10 mM Tris-HCl, 10 mM MgCl2, and 1 mM dithiothreitol
in a population of cells that have been uniformly differen- [pH 7.9]) at 37C for 1 hr. The reactions were stopped by addition
of EDTA to a final concentration of 10 mM. Protease K and SDS weretiated could be a useful way to regulate IL-4-mediated
added to final concentrations of 0.1 mg/ml and 1%, respectively, andfunctions. Since IL-4 largely carries out its effects in the
the samples were incubated at 55C for a minimum of 4 hr. Thecontext of cell/cell interactions rather than at a distance
samples were extracted once with saturated phenol and twice withfrom the IL-4-producer and since some of these effects,
phenol-chloroform. The DNA was then precipitated with ethanol.
such as immunoglobulin class switching, are quantal, Purified DNA (3 g) was ligated overnight to an annealed adaptor
determining whether a cell does or does not produce in a reaction volume of 20 l containing 40 nmol of adaptor and 10
IL-4 may provide a more flexible type of regulation than units of T4 DNA ligase. Samples were stored at –20C or a ligation-
mediated PCR (LM-PCR) was performed immediately.determining the amount of IL-4 produced by all uniformly
A nested PCR strategy was used to identify the sites of linkerdifferentiated cells.
ligation. Samples were amplified for 12 cycles of 1 min at 94C and
2 min at 66C, followed by a final 10 min extension step at 72C.Experimental Procedures:
The primers used in the first-step PCR were a gene specific primer
and a common primer (T7 primer) complementary to the long strandMice and Cells Culture
of the linker. The reaction product (1 l) was then used to performCD4 T cells were purified from 5CC7 transgenic Rag2/ (line 94)
an additional 40 cycles of PCR in a 9700HT Sequence Detectionmice by negative selection with FITC anti-CD8, FITC anti-B220, FITC
System. The probe and primers used in the real-time PCR were aanti-IAK, FITC anti-NK1.1, FITC anti-CD24, and FITC anti-CD16/CD32
gene-specific probe, the gene-specific primer used in the first PCRusing an Automacs. Antigen-presenting cells were purified from
reaction, and a nested common primer (nested primer), which issplenocytes by treatment with anti-Thy1.2 and low-Tox M rabbit
also complementary to the long strand of linker but 3 of the commoncomplement at 37C for 45 min and irradiated. CD4 T cells were
T7 primer. The linearity of the assay does depend upon the linearityprimed with cytochrome C (1 M), APC, and IL-2 (10 ng/ml). For
of the first amplification step.Th1 priming, IL12 (10 ng/ml) and anti-IL4 (10 g/ml) were added;
The oligonucleotides used for the adaptor are: 5-CTA-ATA-CGA-for Th2 priming, IL4 (10 units/ml), anti-IL12 (10 g/ml), and anti-IFN
CTC-ACT-ATA-GGG-CTC-GAG-CGG-CCG-CCC-GGG-CAG-GT-3(10 g/ml) were added. T cells were isolated with anti-CD4 beads
(long strand) and 5-ACC-TGC-CCG-G-3 (short strand). The primersfrom 1 and 2 day cultures; purity was 90%. After 4 day priming,
and probes used for the PCR are: 5-CTA-ATA-CGA-CTC-ACT-ATA-cells were washed and put into IL-2 (10 ng/ml)-containing medium
GGG-C-3 (T7 primer); 5-TCG-AGC-GGC-CGC-CCG-GGC-AGG-to rest. For some experiments, cells were cultured under Th1 or Th2
T-3 (nested primer); 5-CTA-AAG-TGC-GGG-ACC-AGA-CAA-C-3conditions for three rounds of 4 days each. Between each round of
(CNS primer); 5- FAM -AGA-TGG-TGG-CAG-GTG-3(CNS probe);priming, cells were placed in IL-2-containing medium. During prim-
5-GCC-GTC-AGT-GAC-GAG-AGA-CA-3 (IL4-promoter site-106ing and resting, IL-2, to a final concentration of 10 ng/ml, was added
primer); 5-AGC-ATC-TCT-TGA-TAA-AC-3 (IL4-promoter site -106every 4 days. PMA (10 ng/ml) and ionomycin (1 M) were purchased
MGB probe) 5-CCA-ATC-AGC-ACC-TCT-CTT-CCA-3 (IL4-pro-from Calbiochem. EGTA (0.8 mM), cyclosporin A (50 ng/ml), and
moter site -252 primer); 5-CCA-ATT-GGT-CTG-ATT-TC-3 (IL4-pro-cycloheximide (10 g/ml) were purchased from Sigma. They were
put into culture 15 min or 30 min before TCR stimulation. moter site -252 MGB probe); 5-TGC-AGA-GAA-GGA-AGA-GGT-
Immunity
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CAC-A-3 (IL4-promoter site -422 primer); 5-CTG-GTG-TCG-CCC- Ansel, K.M., Lee, D.U., and Rao, A. (2003). An epigenetic view of
helper T cell differentiation. Nat. Immunol. 4, 616–623.TG-3 (IL4-promoter site -422 MGB probe); 5-GCA-CCG-TGT-GGA-
TCC-TTG-A-3 (IL4-promoter site -837 primer); 5-FAM-CAA-GCT- Avni, O., Lee, D., Macian, F., Szabo, S.J., Glimcher, L.H., and Rao,
TGT-GAG-TCT-GA-3 (IL4-promoter site -837 MGB probe); 5-AAC- A. (2002). TH cell differentiation is accompanied by dynamic changes
AGC-ACA-AAT-TGT-GTG-TCT-CCT-AT-3(IL4-HSII primer); 5- in histone acetylation of cytokine genes. Nat. Immunol. 3, 643–651.
FAM–TCC-TAC-CTG-GCC-TTG-3(IL4-HSII MGB probe); 5-AGA-
Bird, J.J., Brown, D.R., Mullen, A.C., Moskowitz, N.H., Mahowald,
GTG-CTT-GCC-TTG-CAA-CCA-TGA-A-3 (IL4-HSIII primer); 5-
M.A., Sider, J.R., Gajewski, T.F., Wang, C.R., and Reiner, S.L. (1998).
FAM-CCA-GCT-GAA-TGT-GAT-T-3 (IL4-HSIII MGB probe); 5-ACT-
Helper T cell differentiation is controlled by the cell cycle. Immunity
TAA-ACA-TTG-CTA-GTG-GCA-AAG-AA-3 (IL4-VA primer); 5-FAM- 9, 229–237.
ACT-GCA-GGA-ACT-GTA-T-3 (IL4-VA MGB probe); 5-CCC-TGC-
Fields, P.E., Kim, S.T., and Flavell, R.A. (2002). Changes in histoneGTA-GTT-TTG-GTG-GTA-A-3 (IFN-HS1 primer); 5-FAM-CCT-
acetylation at the IL-4 and IFN-g loci accompany Th1/Th2 differenti-TAC-CTC-AAT-GGT-T-3 (IFN-HS1 probe); 5-AAT-GCC-TTT-
ation. J. Immunol. 169, 647–650.GGC-CTT-CTA-TGT-AAA-3(IFN-HSIII primer); 5-FAM-ATG-GCC-
GTG-AGA-AT-3(IFN-HSIII probe); 5-CAC-AGC-TTC-TTT-GCA- Gett, A.V., and Hodgkin, P.D. (1998). Cell division regulates the T cell
GCT-CCT-T-3 (
-actin primer); 5-FAM-CGC-CAC-CAG-GTA-A-3 cytokine repertoire, revealing a mechanism underlying immune class
(
-actin MGB probe). regulation. Proc. Natl. Acad. Sci. USA 95, 9488–9493.
Glimcher, L.H., and Murphy, K.M. (2000). Lineage commitment in
Quantitative RT-PCR the immune system: the T helper lymphocyte grows up. Genes Dev.
Total RNA was isolated using RNase minicolumn (Qiagen treating 14, 1693–1711.
with RNase free DNaseI; first-strand cDNA was prepared using Su-
Grogan, J.L., and Locksley, R.M. (2002). T helper cell differentiation:
perscript Pre-amplification System (Invitrogen). The primers and
on again, off again. Curr. Opin. Immunol. 14, 366–372.
probe for gata3 are: 5-CAG-AAC-CGG-CCC-CTT ATC-A-3; 5-
Guo, L., Hu-Li, J., Zhu, J., Watson, C.J., Difilippantonio, M.J.,CAT-TAG-CGT-TCC-TCC-TCC-AGA-3 and 5-FAM-CGA-AGG-CTG-
Pannetier, C., and Paul, W.E. (2002). In TH2 cells the Il4 gene hasTCG-GCA-3, respectively. The primer for c-maf are: 5-CAG-TCC-
a series of accessibility states associated with distinctive probabili-TGC-CGC-TTC-AAG-A-3; 5-CGC-ACC-AGC-CTG-GAG-ATC-T-3
ties of IL-4 production. Proc. Natl. Acad. Sci. USA 99, 10623–10628.and 5-FAM-TGC-AGC-AGA-GAC-ACG-T-3, respectively. The
primer and probe sets for murine IL-4 and the TaqMan Ribosomal Henkel, G., Weiss, D.L., McCoy, R., Deloughery, T., Tara, D., and
RNA Control Reagents for detecting the 18S ribosomal RNA (VIC Brown, M.A. (1992). A DNase I-hypersensitive site in the second
MGB Probe) were purchased from Applied Biosystems. intron of the murine IL-4 gene defines a mast cell-specific enhancer.
J. Immunol. 149, 3239–3246.
Confocal Fluorescence Microscopy Ho, I.C., Hodge, M.R., Rooney, J.W., and Glimcher, L.H. (1996). The
Two-round primed Th2 cells were stimulated for 4 hr on a coverslip proto-oncogene c-maf is responsible for tissue-specific expression
on which anti-CD3/CD28 had been immobilized. Cells were then of interleukin-4. Cell 85, 973–983.
fixed with 4% paraformaldehyde for 10 min and permeabilized with
Hu-Li, J., Pannetier, C., Guo, L., Lohning, M., Gu, H., Watson, C.,
0.2% Triton X-100 in PBS for 10 min. Staining was performed for
Assenmacher, M., Radbruch, A., and Paul, W.E. (2001). Regulation
45 min with anti-NFATc2 antiserum (1:200) and a monoclonal anti-
of expression of IL-4 alleles: analysis using a chimeric GFP/IL-4
IL-4 (1 g/ml). After extensive wash, Alexa-594-labeled goat anti-
gene. Immunity 14, 1–11.
rabbit second antibody (1:600) and Alexa-488-labeled donkey
Kim, J.I., Ho, I.C., Grusby, M.J., and Glimcher, L.H. (1999). The tran-anti-rat second antibody (1:600) were used to reveal NFATc2 and
scription factor c-Maf controls the production of interleukin-4 butIL-4, respectively. Stained cells were visualized with a Leica CNS-
not other Th2 cytokines. Immunity 10, 745–751.NT-SP confocal microscope (Leica Microsystems, Milton Keynes,
UK). Anti-NFATc2 antiserum was kindly provided by Dr. Anjana Rao. Lee, H.J., Takemoto, N., Kurata, H., Kamogawa, Y., Miyatake, S.,
Anti-IL-4 antibody was from BD Pharmingen. Both Alexa labeled O’Garra, A., and Arai, N. (2000). GATA-3 induces T helper cell type
secondary antibodies were from Molecular Probes. The degree of 2 (Th2) cytokine expression and chromatin remodeling in committed
nuclear NFAT and the ratio of nuclear to cytoplasmic NFAT were Th1 cells. J. Exp. Med. 192, 105–115.
evaluated both visually, using a scoring system that assigned 1–3 Lee, G.R., Fields, P.E., and Flavell, R.A. (2001a). Regulation of IL-4
points for nuclear NFAT intensity and 0–2 points for nuclear/cyto- gene expression by distal regulatory elements and gata-3 at the
plasmic ratio. In addition, NFAT localization was evaluated by the chromatin level. Immunity 24, 447–459.
ImarisCoLoc analysis programs.
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